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Abstract
Identifying possible environmental or infectious etiologic factors for eosinophilic esophagitis 
(EoE) may offer insight into opportunities for disease prevention and treatment. We reviewed the 
current literature to assess environmental and infectious factors evaluated in EoE. Few studies 
have been conducted, however a consistent inverse association between EoE and H. pylori has 
been described. Several studies suggest a weak association between season and EoE diagnosis, but 
the evidence is inconclusive. EoE has also been associated with early life factors, including 
Cesarean delivery and antibiotic use. Larger studies are needed to evaluate these associations more 
thoroughly. Several papers have speculated the potential for anti-secretory agents to contribute to 
EoE. This has not been formerly evaluated. In summary, there is significant opportunity in the 
future to advance our understanding of possible environmental etiologic factors for EoE.
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Introduction
Much of the literature on eosinophilic esophagitis (EoE) focuses on either clinical aspects of 
the disease, i.e. diagnosis, treatment, and natural history, or the underlying molecular 
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pathways for disease development and progression. Additionally, several studies have 
examined the descriptive epidemiology of EoE (i.e. estimating disease incidence, prevalence 
and demographic features of affected patients).(1–12) Although these studies have greatly 
enhanced our understanding of this increasingly common disease,(13, 14) our understanding 
of etiologic risk factors for disease remains elusive. Studies of genetics have identified 
several susceptibility loci for disease development,(15–18) and these are described 
elsewhere in this issue, but recent family studies suggest that relatively little of the disease 
can be explained by heritability alone.(19) This, together with the rapidly increasing 
incidence of disease that is not entirely explained by increased diagnostic awareness or 
volume of upper endoscopy procedures,(9, 12, 20) suggests that environmental factors not 
only contribute, but likely play a large role in EoE etiology. Understanding which 
environmental factors contribute to disease development is not simply an academic exercise. 
Identifying etiologic risk factors for disease offers the opportunity to improve our 
understanding of disease pathogenesis, thus helping us to identify opportunities for 
prevention, as well as treatment targets that may interrupt disease course.
In this review, we discuss the literature published to date on environmental and infectious 
etiologic factors in development of EoE. We focus on the several areas of research that have 
been explored thus far, including seasonal and geographical differences, possible infectious 
origins of disease, perinatal and early childhood factors that may contribute, and 
pharmacologic risk factors, specifically use of anti-secretory agents. In each of these areas of 
research we discuss the existing evidence in support of these factors contributing to disease 
development and, where applicable, identify opportunities for future research. While food 
triggers, may be considered an environmental cause of EoE, a detailed review of the role of 
allergy and food antigens is beyond the scope of this paper, and this topic is addressed 
elsewhere in this issue.
Seasonal differences
The question of possible seasonal differences in diagnosis of EoE has been evaluated in 
several studies. Identifying seasonal differences in the distribution of disease diagnosis 
would provide support to the literature suggesting that aeroallergens are associated with 
disease pathogenesis,(21–24) and the subject of aeroallergens is explored in detail elsewhere 
in this issue. Generally, most of the studies conducted on season and EoE are suggestive of a 
modest association, typically with an increase in diagnosis in the Summer or Fall months.
(12, 25–32) Most of these studies, however, have been conducted at single center sites and 
were unable to account for possible climate differences (Table 1).
Although seasonal differences in aeroallergens are the most obvious explanation for any 
association between season and EoE, there are other factors that vary by season, including 
differences in dietary patterns due to availability of fresh produce and differences in air 
quality in different seasons. Diet related triggers for EoE have been explored extensively, as 
these form the basis for food-related therapeutic approaches to treatment for EoE. Air 
quality factors have not been directly studied in EoE, but have been associated with 
development of other atopic diseases.(33–35)
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A difference in the geographical distribution of disease has been documented for other 
gastrointestinal diseases although only a few studies have evaluated this in EoE. Any 
differences observed could provide clues into possible environmental contributors to disease 
etiology. A single-center, case control study (n=508 cases, n=508 GI controls, and n=508 
allergy controls) conducted in the Greater Philadelphia area observed that patients diagnosed 
with EoE were more likely to reside in suburban areas when compared to allergy clinic 
identified controls (adjusted OR: 2.08; 95% CI: 1.22, 3.54).(36) However, no association 
was found when comparing EoE patients to GI clinic obtained controls (adjusted OR: 0.82; 
95% CI: 0.46, 1.45).(36) A case-control study (n=14,381 cases and n=89,754 controls), 
using a large pathology database with cases from throughout the U.S. identified an 
association between EoE and population density, with increasingly rural areas exhibiting 
increasingly higher odds of diagnosis (adjusted OR: 1.41; 95% CI: 1.14, 1.76 for the least 
populous zip code residences).(37) The association was robust to using a variety of case 
definitions with increased specificity for EoE. While increased odds of EoE in rural areas is 
somewhat counter to what has been found in other allergic diseases, a similar finding was 
noted in a survey study of gastroenterologists and allergists.(38) Another study, from the 
large national pathology database noted above, observed that the prevalence of EoE varied 
by climate zone, with cold climate zones exhibiting the greatest odds of disease as compared 
to temperate climates (adjusted OR: 1.39; 95% CI: 1.34, 1.47).(39)
The implications of this variation in geographical distribution are that there may be 
environmental factors associated with population density or climate that are contributing to 
disease etiology, although direct study of these factors is needed. For lower population 
density areas, there may be agricultural exposures, different foliage patterns, or differences 
in particulate matter size or species that contribute. These hypotheses are speculative, but 
these studies provide support for additional investigation.
Infectious origins
Helicobacter pylori
While most studies examining risk factors for EoE have looked for environmental factors 
that are increasing in association with the increase in EoE, it is also possible to look for 
something that has been decreasing in the environment. Helicobacter pylori is one such 
potential factor. Since it’s identification as a major cause of peptic ulcer disease and gastric 
cancer, H. pylori has been eradicated when found, leading to decreasing rates of 
colonization and infection throughout the U.S.(40, 41) Additionally, this decrease in H. 
pylori has been associated with the increase of other atopic conditions, including asthma, 
allergic rhinitis, and atopic dermatitis.(42–45)
Recently, a series of studies has demonstrated that H. pylori is also inversely associated with 
EoE. This observation appears to hold in both adult and pediatric populations and in 
multiple settings (Table 2).(46–50) For example, in the largest of these studies (n=5,767 
cases, n=56,301 controls) which used a national pathology database from biopsies obtained 
in 41 states throughout the U.S., the odds of EoE among patients with conformed H. pylori 
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infection was 0.79 (95% CI: 0.70, 0.88). While the underlying reason for this inverse 
association is not known, and causality has yet to be determined in an experimental model, it 
is possible that lack of H. pylori either has a direct effect (Th2 vs Th2 polarization), or that it 
is a marker for the hygiene hypothesis.(46) The underlying premise for this hypothesis is 
that the lack of exposure to childhood infections and improved sanitation has caused a lack 
of immune tolerance.(42, 51, 52) However, whether this applies to EoE has yet to be 
examined directly. Alternatively, H. pylori has also been inversely associated with 
gastroesophageal reflux disease (53). Given the association between EoE and reflux, it may 
be that the decrease in H. pylori is driven by the inverse association shared between GERD 
and H. pylori. This hypothesis also requires additional future investigation.
Herpes Simplex Virus and other potential infectious etiologies
Case reports of herpes simplex virus (HSV) esophagitis and subsequent development of EoE 
suggest that there may be a potential link between these two conditions. In a case series from 
Melbourne, Australia, three children (ages 9–16) presented with herpetic esophagitis.(54) 
While none had evidence of EoE at the time HSV positive biopsies were obtained from the 
esophagus, all three developed esophageal eosinophil infiltration consistent with EoE (all 
had > 30 eos/hpf) within the following 1–2 months. All three patients had history of atopy, 
suggesting there may have been an underlying predisposition toward EoE. In a similar case 
report, a 17 year old adolescent with concomitant atopy presented with signs of both herpes 
esophagitis and EoE at the initial endoscopy.(55) Subsequent biopsy showed increased 
eosinophils (34 eos/hpf) and the presence of HSV I. Follow-up at 2 and 3 months indicated 
resolution of HSV but persistent EoE. Despite these isolated cases, as well as ones that 
report HSV as complicating topical steroid therapy in EoE,(56) additional research is needed 
to assess the extent to which these conditions co-exist, the temporality in the association 
between the conditions, and whether herpes simplex esophagitis is a causal agent in 
susceptible individuals.(57, 58)
Other infections that have been examined in relation to EoE are mycoplasma pneumonia and 
IgE sensitization from tick-borne, galactose-alpha-1,3-galactose (alpha gal). For m. 
pneumonia, 10 of 12 children were IgG positive with serologic testing for m. pneumonia.
(59) However, further study is needed to establish the seroprevalence of IgG for m. 
pneumonia in controls before any association with EoE can be inferred.
In a case-control study (n=50 cases, n=50 controls), sera biobanked from adult EoE cases 
and controls undergoing upper endoscopy were evaluated for IgE sensitization for alpha gal. 
This study found a high rate of sensitization in both cases and controls being seen for upper 
endoscopy, but no difference between cases and controls in the absolute IgE count or 
proportion with sensitization (defined as > 0.35 kUA/L).(60) Therefore, it does not appear 
that the recent discovery of a tick-induced food allergy is a risk factor for EoE.
Early life factors
To date, few studies have explored early life factors associated with the development of 
EoE, but based on parallels with other atopic conditions, understanding this critical time 
period is an important future direction for EoE research. For example, allergic and other 
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immune-mediated diseases have been hypothesized to be associated with changes in gut 
microbiota in early life potentially resulting from changes in diet, antibiotic exposure, 
Cesarean deliveries, infant feeding practices and breast milk exposure, and reduced exposure 
to microbial disease (the hygiene hypothesis).(46, 61–65) Preliminary data suggest that 
similar risk factors could be important in EoE. In a case-control study of 31 children with 
EoE, there was an association between certain early life factors and development of EoE in 
children.(66) These factors included cesarean delivery, preterm delivery, and antibiotic use 
in infancy, although only antibiotic use in the first year of life reached statistical significance 
(OR 6.1, 95% CI: 1.7, 20.8). Another small case control study (25 EoE cases) recently 
reported similar results, with both cesarean delivery and antibiotic use in the first year of life 
associated with EoE (OR 3.2 (95% CI 1.2, 8.6) and 3.6 (95% CI 1.3, 10.1) respectively).(67) 
These studies, although suggestive of the potential for early life factors contributing to 
disease pathogenesis, were based on data collected from questionnaires and may be subject 
to recall bias, or, for antibiotic use, subject to confounding by indication. Moreover, there 
are no studies in EoE that show that an alteration of the microbiome is directly responsive 
for disease onset. Therefore, additional larger and mechanistic studies are warranted to 
explore these associations further.
Anti-secretory agents
Because proton pump inhibitors (PPIs) are one of the most commonly used medications 
(68), were introduced more than 30 years ago around the time of the first cases reports of 
EoE,(69) and have had markedly increasing use infants in recent years, (70, 71) it is 
intriguing to speculate whether there is an association between PPIs and EoE. In 2009, 
Merwat and Spechler commented on the potential for anti-secretory agents to cause EoE.
(72) They posited that H2 receptor antagonists and PPIs alter the permeability of the mucosa 
in the upper gastrointestinal tract and could allow increased uptake of allergens, 
subsequently leading to recruitment of eosinophils. While this has never been shown in EoE, 
this hypothesis is informed by studies showing that patients with reflux esophagitis and 
Barrett’s esophagus taking anti-secretory agents have increased mucosal permeability to 
sucrose,(73) similar to the increased mucosal permeability seen in animal models following 
use of an anti-secretory agent.(74) Increased gut permeability, in genetically susceptible 
individuals, may compromise oral tolerance and lead to development of food allergies. In 
animal models and human studies, antacid medications have inhibited digestion of dietary 
proteins and resulted in development of IgE antibodies in response to the dietary protein.
(75–77). PPIs have also been associated with hypersensitivity reactions to medications in 
hospitalized patients.(78) Observational studies have suggested that use of an anti-secretory 
agent in pregnancy can increase risk of atopic illness in the offspring,(79–81) but the 
mechanism is unknown. One possibility that has been raised is that maternal use of these 
agents could interfere with normal digestion of dietary proteins, possibly resulting in 
preservation of antigens that could be transferred to and induce a Th2 response in the fetus.
(82–84)
Because the possible association between anti-secretory agents and EoE has not been 
formally assessed, this theory remains controversial and there is an active debate in the 
literature. For example, in one report, there was no evidence of either an absolute increase in 
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EoE or a dose-response among PPI users after 400 patients undergoing outpatient upper 
endoscopy were assessed.(85) In contrast, three cases of EoE have been reported following 
PPI use after an initial diagnosis of either reflux esophagitis or infectious esophagitis.(25, 
86) Finally, at least one study has suggested that PPIs can decrease the permeability of the 
esophageal mucosa in GERD patients.(87) As with many of the potential risk factors of 
EoE, additional work is needed to clarify the importance of these associations.
Research agenda
• Environmental changes are likely key in the development of EoE, but few studies 
have been conducted on possible non-food environmental factors that may 
contribute to the pathogenesis of EoE.
• Recent data have suggested that EoE is associated with seasonality, climate zone, 
and geographic factors such as population density. However, additional work is 
needed to determine the specific triggers associated with these factors.
• An inverse association between H. pylori and EoE has been demonstrated in a 
number of studies. Whether this relation is causal, and what mechanisms might 
underlie this, however, have yet to be investigated.
• Early life factors may contribute to disease development, potentially through 
immune dysregulation. Two small studies suggest are suggestive of an association 
with cesarean delivery and antibiotic use in early life, however larger studies are 
needed.
• Speculation that anti-secretory agents may be associated with EoE is intriguing but 
controversial, and warrants further investigation. However, confounding by 
indication and recall bias, as well as the availability of these medications over the 
counter, will be issues in such studies.
Summary
Identifying etiologic risk factors for EoE offers the opportunity to improve our 
understanding of disease pathogenesis, thus helping us to identify opportunities for 
prevention, as well as treatment strategies that may interrupt disease course. Heritability 
explains relatively little of disease development and thus, environmental factors are 
important. However, few studies have been conducted on possible environmental factors 
that may contribute to the pathogenesis of EoE. The studies conducted to date suggest that 
geography (rural location; cold or arid climate zones), absence of H. pylori infection, and 
early life factors (antibiotic use during infancy; Cesarean delivery), which might alter gut 
microbiota, are associated with disease development. With few exceptions, most studies 
conducted have been relatively small, and have not been confirmed by mechanistic 
investigations. Therefore, the association between environment and EoE is an 
underdeveloped but important area of research in the field.
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